Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.14% is 41% below its 5-year average of 5.37%, near the low end of its 5-year range (1.50%–11.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.27% below its 12-month average of 4.26%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.14%.
DEBT TO ASSETS RATIO
3.14%
DEBT TO ASSETS RATIO AVG TTM
4.26%
DEBT TO ASSETS RATIO AVG 3Y
3.71%
DEBT TO ASSETS RATIO AVG 5Y
5.37%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.27%
CURRENT VS 3Y AVG
-15.40%
CURRENT VS 5Y AVG
-41.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.28%
median of 102 covered companies
CURRENT VS SECTOR MEDIAN
+1022.08%
vs the sector median at left
Inspire Medical Systems, Inc.
Market Cap
$2.02B
Debt to Assets Ratio
3.14%
TTM Avg
4.26%
3Y Avg
3.71%
5Y Avg
5.37%
Market Cap
$1.90B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.16B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.52B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.76B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | $2.02B | 3.14% | 4.26% | 3.71% | 5.37% |
| Fortrea Holdings Inc. (FTRE)vs › | $1.90B | 0.41% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | 0.05% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 0.44% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 0.09% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | 0.18% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 0.59% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.38% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | 0.33% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $458.62M | 0.66% | N/A | N/A | N/A |
Debt/Assets
3.1%
Debt/Equity
0.04
Current Ratio
8.55
Interest Coverage
371.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.14% |
| 2026-03-31 | 3.24% |
| 2025-12-31 | 6.77% |
| 2025-09-30 | 4.03% |
| 2025-06-30 | 4.12% |
| 2025-03-31 | 4.59% |
| 2024-12-31 | 3.93% |
| 2024-09-30 | 3.18% |
| 2024-06-30 | 3.37% |
| 2024-03-31 | 3.57% |
| 2023-12-31 | 3.67% |
| 2023-09-30 | 3.94% |
| 2023-06-30 | 3.78% |
| 2023-03-31 | 1.50% |
| 2022-12-31 | 1.57% |
| 2022-09-30 | 1.73% |
| 2022-06-30 | 10.73% |
| 2022-03-31 | 11.83% |
| 2021-12-31 | 11.55% |
| 2021-09-30 | 11.13% |
| 2021-06-30 | 11.35% |
| 2021-03-31 | 11.25% |
| 2020-12-31 | 10.89% |
| 2020-09-30 | 9.12% |
| 2020-06-30 | 9.20% |
| 2020-03-31 | 15.18% |
| 2019-12-31 | 13.99% |
| 2019-09-30 | 13.35% |
| 2019-06-30 | 13.16% |
| 2019-03-31 | 12.85% |
| 2018-12-31 | 12.46% |
| 2018-09-30 | 18.98% |
| 2018-06-30 | 18.44% |
| 2018-03-31 | 88.21% |
| 2017-12-31 | 65.60% |
